Your browser doesn't support javascript.
loading
Five years after treat all implementation: Botswana's HIV response and future directions in the era of COVID-19
Jefferis, Keith; Avalos, Ava; Phillips, Heston; Mmelesi, Mpho; Ramaabya, Dinah; Nkomo, Bornapate; Muthoga, Charles; Jarvis, Joseph N; Ratladi, Siphiwe; Selato, Robert; Stover, John.
  • Jefferis, Keith; E-consult Botswana. Gaborone. BW
  • Avalos, Ava; Careena Centre for Health. Gaborone. BW
  • Phillips, Heston; UNAIDS. Lusaka. ZM
  • Mmelesi, Mpho; UNAIDS. Gaborone. BW
  • Ramaabya, Dinah; Botswana Ministry of Health and Wellness. Gaborone. BW
  • Nkomo, Bornapate; Botswana Ministry of Health and Wellness. Gaborone. BW
  • Muthoga, Charles; Botswana Harvard AIDS Institute Partnership. Gaborone. BW
  • Jarvis, Joseph N; Botswana Harvard AIDS Institute Partnership. Gaborone. BW
  • Ratladi, Siphiwe; National AIDS and Public Health Agency. Gaborone. BW
  • Selato, Robert; National AIDS and Public Health Agency. Gaborone. BW
  • Stover, John; Avenir Health. Glastonbury. US
South. Afr. j. HIV med. (Online) ; 22(1): 1-11, 2021. Tables, figures
Article in English | AIM | ID: biblio-1338036
ABSTRACT

Background:

As the relentless coronavirus disease-2019 (COVID-19) pandemic continues to spread across Africa, Botswana could face challenges maintaining the pathway towards control of its HIV epidemic.

Objective:

Utilising the Spectrum GOALS module (GOALS-2021), the 5-year outcomes from the implementation of the Treat All strategy were analysed and compared with the original 2016 Investment Case (2016-IC) projections. Future impact of adopting the new Joint United Nations Programme on HIV/AIDS (UNAIDS) Global AIDS Strategy (2021­2026) targets and macroeconomic analysis estimating how the financial constraints from the COVID-19 pandemic could impact the available resources for Botswana's National HIV Response through 2030 were also considered.

Method:

Programmatic costs, population demographics, prevention and treatment outputs were determined. Previous 2016-IC data were uploaded for comparison, and inputs for the GOALS, AIM, DemProj, Resource Needs and Family Planning modules were derived from published reports, strategic plans, programmatic data and expert opinion. The economic projections were recalibrated with consideration of the impact of the COVID-19 pandemic.

Results:

Decreases in HIV infections, incidence and mortality rates were achieved. Increases in laboratory costs were offset by estimated decreases in the population of people living with HIV (PLWH). Moving forward, young women and others at high risk must be targeted in HIV prevention efforts, as Botswana transitions from a generalised to a more concentrated epidemic.

Conclusion:

The Treat All strategy contributed positively to decreases in new HIV infections, mortality and costs. If significant improvements in differentiated service delivery, increases in human resources and HIV prevention can be realised, Botswana could become one of the first countries with a previously high-burdened generalised HIV epidemic to gain epidemic control, despite the demands of the COVID-19 pandemic.
Subject(s)

Full text: Available Index: AIM (Africa) Main subject: Therapeutics / HIV Infections / COVID-19 Language: English Journal: South. Afr. j. HIV med. (Online) Year: 2021 Type: Article Institution/Affiliation country: Avenir Health/US / Botswana Harvard AIDS Institute Partnership/BW / Botswana Ministry of Health and Wellness/BW / Careena Centre for Health/BW / E-consult Botswana/BW / National AIDS and Public Health Agency/BW / UNAIDS/BW / UNAIDS/ZM

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: AIM (Africa) Main subject: Therapeutics / HIV Infections / COVID-19 Language: English Journal: South. Afr. j. HIV med. (Online) Year: 2021 Type: Article Institution/Affiliation country: Avenir Health/US / Botswana Harvard AIDS Institute Partnership/BW / Botswana Ministry of Health and Wellness/BW / Careena Centre for Health/BW / E-consult Botswana/BW / National AIDS and Public Health Agency/BW / UNAIDS/BW / UNAIDS/ZM